Cardiovascular diseases: Oxidative damage and antioxidant protection

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 20, 2014, Pages 3091-3096

  Zhang, P Y ^a   Xu, X ^b   Li, X C ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b Department of Radiology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE; ALPHA TOCOPHEROL; ANTIOXIDANT; ARACHIDONIC ACID; ARYLDIALKYLPHOSPHATASE; ASCORBIC ACID; BETA CAROTENE; BIOLOGICAL MARKER; CHOLESTEROL ESTER; DOCOSAHEXAENOIC ACID; HYDROXY FATTY ACID; ICOSAPENTAENOIC ACID; ISOPROSTANE DERIVATIVE; LIPID PEROXIDE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PEROXIREDOXIN; SUPEROXIDE DISMUTASE; FREE RADICAL; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANTIOXIDANT ACTIVITY; ARTERY WALL; ATHEROSCLEROSIS; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL ADHESION; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; HEART MUSCLE; HEART PROTECTION; HUMAN; INFLAMMATION; LIPID PEROXIDATION; MACROPHAGE; MONOCYTE; OXIDATIVE STRESS; REVIEW; SMOKING; THROMBOSIS; VITAMIN SUPPLEMENTATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CARDIOVASCULAR DISEASES; DIET; DRUG EFFECTS; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BETA CAROTENE; CARDIOVASCULAR DISEASES; DIET; FREE RADICALS; HUMANS; LIPID PEROXIDATION; LIPID PEROXIDES; LIPOPROTEINS, LDL; OXIDATION-REDUCTION; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

EID: 84940040868     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. AVIRAM M. Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases. Free Radical Res 2000; 33(Suppl): S85-97.
2. KAYA Z, SALIH AYDIN M, HAZAR A, CAN ATA E, SEZEN H, YILDIZ A, DEMIRBAG R, AKSOY N. Association of serum paraoxonase activity and coronary artery calcification. Eur Rev Med Ph armacol Sci 2013; 17: 2121-2126.
3. SINGAL PK, KHAPER N, PALACE V, KUMAR D. The role of oxidative stress in the genesis of heart disease. Cardiovasc Res 1998; 40: 426-432.
4. JACOB RA, BURRI BJ. Oxidative damage and defense. Am J Clin Nutr 1996; 63: 985S-990S.
5. BASSON M. Cardiovascular disease. Nature 2008; 451, 903-957. http://www.nature.com/nature/supplements/insights/cardiovascular/
6. National Centre for Biotechnology Information, 2014; NIM, NIH, Md, USA http://www.ncbi.nlm. nih.gov
7. THROMBOSIS. Bayer Pharma AG, 20 14; http://www.thrombosisadviser.com/
8. LOSCALZO J. Paraoxonase and coronary heart disease risk: language misleads, linkage misinforms, function clarifies. Circ Cardiovasc Genet 2008; 1: 79-80.
9. AMERICAN HEART FOUNDATION. Oxidative stress & hear t disease. Washington, DC, USA. 2014; http://www.heart.org/HEARTORG
10. WEBMD, USA, CARDIOVASCULAR DISEASE: oxidative stress and antioxidants. 2014; http://www.webmd. com/heart-disease/
11. JA KUBAWS K I H. Calcium dependant human serum homocys-teine thiolactone hydrolase a protective mechanism against protein N-homocysteinylation. J Biol Chem 2000; 275: 3957-3962.
12. BHARTI M, DURRINGTON P, MCELDUFF P, YARNELL J, AZAM, WATT M, MACKNESS M. Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study. Circulation 2003; 107: 2775-2779.
13. POH R, MUNIAN DY S. Paraoxonase 1 activity as a predictor of cardiovascular disease in type 2 diabetes. Southeast Asian J Trop Med Public Health 2010; 41: 1231-1246.
14. RICHTER RJ, JAMPSA RL, JARVIK GP, COST A LG, FURLONG CE. Determination of paraoxonase 1 status and genotypes at specific polymorphic sites. Curr Protoc Toxicol 2004; Chapter 4: Unit 4.12.
15. SENTI M, TOMAS M, MARRUGAT J, ELOSUA R; REGICO R Investigators. Paraoxonase1-192 polymorphism modulates the nonfatal myocardial infarction risk associated with decreased HDLs. Arterioscler Thromb Vasc Biol 2001; 21: 415-420.
16. SUBASH VK, SARITHA G, FAREEDULLAH MD. The role of antioxidants and oxidative stress in cardiovascular disease. Ann Biol Res 2010; 1: 158-173.
17. MARX JL. Oxygen free radicals linked to many diseases. Science 1987; 235: 529-531.
18. MAYERS ML. Enhancement of recovery of myocardial function. Circulation 1985; 72: 915-921.
19. MARITIM AC, SANDERS RA, WATKINS JB 3RD. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003; 17: 24-38.
20. HALLIWELL B, GUTTERIDGE JMC. Free Radicals in Biology and Medicine. 2nd ed. Clarendo Press, Oxford, UK, 1989.
21. BOULLIER A, BIRD DA, CHANG MK, DENNIS EA, FRIEDMAN P, GILLOTRE-TAYLOR K, HÖRKKÖ S, PALINSKI W, QUEHENBERGER O, SHAW P, STEINBERG D, TERPSTRA V, WITZTUM JL. Scavenger receptors, oxidized LDL, and atherosclerosis. Ann N Y Acad Sci 2001; 947: 214-222; discussion 222-223.
22. TANDON VR, VERMA S, SINGH JB, MAHAJAN A. Role of antioxidants and oxidative stress in cardiovascular diseases. Drug Review, JK Science 2005; 7: 61-63.
23. MAHAJAN A, TANDON VR. Role of antioxidants and oxidative stress in cardiovascular diseases. J Ind Rheumotol Assoc 2004; 12: 39-42.
24. JOHANSEN JS, HARRIS AK, RYCHLY DJ, ERGUL A. Oxidative stress an d the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc Diabetol 2005; 4: 5.
25. NOZIK-GRAYCK E, SULIMAN HB, PIANTADOSI CA. Extracellular superoxide dismutase. Int J Biochem Cell Biol 2005; 37: 2466-2471.
26. OGATA M. Acatalasemia. Hum Genet 1991; 86: 331-340.
27. PARSONAGE D, YOUNGBLOOD D, SARMA G, WOOD Z, KARPLUS P, POOLE LB. Analysis of the link between enzymatic activity and oligomeric state in AhpC, a bacterial peroxiredoxin. Biochemi stry 2005; 44: 10583-10592.
28. DIETZ K, JACOB S, OELZE M, LAXA M, TOGNETTI V, DE MIRANDA S, BAIER M, FINKEMEIER I. The function of peroxiredoxins in plant organelle redox metabolism. J Exp Bot 2006; 57: 1697-1709.
29. KIM SH, KIM JS, SHIN HS, KEEN CL. Influence of smoking on markers of oxidative stress and serum mineral concentrations in teenage girls in Korea. Nutrition 2003; 19: 240-243.
30. YILDIZ L, KAYAOGLU N, AKSOY H. The changes of superoxide dismutase, catalase and glutathione peroxidase activities in erythrocytes of active and passive smokers. Clin Chem Lab Med 2002; 40: 612-615.
31. DI RENZO L, DI PIERRO D, BIGIONI M, SODI V, GALVANO F, CIANCI R, LA FAUCI L, DE LORENZO A. Is antioxidant plasma status in humans a consequence of the antio xidant food content influence? Eur Rev Med Pharmacol Sci 2007; 11: 185-192.